Publikationen in Zusammenarbeit mit Forschern von Leeds and York Partnership NHS Foundation Trust (23)

2019

  1. Autologous stem cell transplantation for HIV-associated lymphoma in the antiretroviral and rituximab era: a retrospective study by the EBMT Lymphoma Working Party

    Bone Marrow Transplantation, Vol. 54, Núm. 10, pp. 1625-1631

  2. Clinical Implication of Quantitative Flow Ratio After Percutaneous Coronary Intervention for 3-Vessel Disease

    JACC: Cardiovascular Interventions, Vol. 12, Núm. 20, pp. 2064-2075

  3. Expert consensus document: Reporting checklist for quantification of pulmonary congestion by lung ultrasound in heart failure

    European Journal of Heart Failure, Vol. 21, Núm. 7, pp. 844-851

  4. PTCy-based haploidentical vs matched related or unrelated donor reduced-intensity conditioning transplant for DLBCL

    Blood Advances, Vol. 3, Núm. 3, pp. 360-369

  5. Week 96 efficacy and safety results of the phase 3, randomized EMERALD trial to evaluate switching from boosted-protease inhibitors plus emtricitabine/tenofovir disoproxil fumarate regimens to the once daily, single-tablet regimen of darunavir/cobicistat/emtricitabine/tenofovir alafenamide (D/C/F/TAF) in treatment-experienced, virologically-suppressed adults living with HIV-1

    Antiviral Research, Vol. 170

2018

  1. Efficacy of bendamustine and rituximab as first salvage treatment in chronic lymphocytic leukemia and indirect comparison with ibrutinib: A GIMEMA, ERIC and UK CLL FORUM study

    Haematologica, Vol. 103, Núm. 7, pp. 1209-1217

  2. Global overview of the transnational alliance for regenerative therapies in cardiovascular syndromes (TACTICS) Recommendations: A comprehensive series of challenges and priorities of cardiovascular regenerative medicine

    Circulation Research, Vol. 122, Núm. 2, pp. 199-201

  3. Guideline-indicated treatments and diagnostics, GRACE risk score, and survival for non-ST elevation myocardial infarction

    European Heart Journal, Vol. 39, Núm. 42, pp. 3798-3806

  4. Indications and practical approach to non-invasive ventilation in acute heart failure

    European Heart Journal, Vol. 39, Núm. 1, pp. 17-25

2017

  1. Allergen immunotherapy for IgE-mediated food allergy: a systematic review and meta-analysis

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 72, Núm. 8, pp. 1133-1147

  2. Performance of hospitals according to the ESC ACCA quality indicators and 30-day mortality for acutemyocardial infarction: National cohort study using the United KingdomMyocardial Ischaemia National Audit Project (MINAP) register

    European Heart Journal, Vol. 38, Núm. 13, pp. 974-982

  3. Prosthetic joints: shining lights on challenging blind spots

    International Journal of Antimicrobial Agents

  4. β-Blockers and Mortality After Acute Myocardial Infarction in Patients Without Heart Failure or Ventricular Dysfunction

    Journal of the American College of Cardiology, Vol. 69, Núm. 22, pp. 2710-2720

2016

  1. Allergen immunotherapy for IgE-mediated food allergy: Protocol for a systematic review

    Clinical and Translational Allergy, Vol. 6, Núm. 1

  2. Association of clinical factors and therapeutic strategies with improvements in survival following Non-ST-elevation myocardial infarction, 2003-2013

    JAMA - Journal of the American Medical Association, Vol. 316, Núm. 10, pp. 1073-1082

  3. Contemporary roles of registries in clinical cardiology: Insights from Western and Eastern European countries

    International Journal of Cardiology, Vol. 217, pp. S13-S15

  4. The race for higher sensitivity troponins, but for what prize?

    European Heart Journal, Vol. 37, Núm. 30, pp. 2425-2427

2015

  1. Development and Validation of a Risk Score for Chronic Kidney Disease in HIV Infection Using Prospective Cohort Data from the D:A:D Study

    PLoS Medicine, Vol. 12, Núm. 3

  2. Plan de estudios universitarios en medicina geriátrica desarrollado utilizando una técnica internacional Delphi modificada

    Revista Espanola de Geriatria y Gerontologia, Vol. 50, Núm. 2, pp. 82-88

  3. Precautionary allergen labelling: Perspectives from key stakeholder groups

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 70, Núm. 9, pp. 1039-1051